Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr−/− mice

Altered metabolism is an important regulator of macrophage (MΦ) phenotype, which contributes to inflammatory diseases such as atherosclerosis. Broadly, pro-inflammatory, classically-activated MΦs (CAM) are glycolytic while alternatively-activated MΦs (AAM) oxidize fatty acids, although overlap exist...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Atherosclerosis 2017-11, Vol.266, p.182-189
Hauptverfasser: Zhao, Liyang, Cozzo, Alyssa J., Johnson, Amy R., Christensen, Taylor, Freemerman, Alex J., Bear, James E., Rotty, Jeremy D., Bennett, Brian J., Makowski, Liza
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 189
container_issue
container_start_page 182
container_title Atherosclerosis
container_volume 266
creator Zhao, Liyang
Cozzo, Alyssa J.
Johnson, Amy R.
Christensen, Taylor
Freemerman, Alex J.
Bear, James E.
Rotty, Jeremy D.
Bennett, Brian J.
Makowski, Liza
description Altered metabolism is an important regulator of macrophage (MΦ) phenotype, which contributes to inflammatory diseases such as atherosclerosis. Broadly, pro-inflammatory, classically-activated MΦs (CAM) are glycolytic while alternatively-activated MΦs (AAM) oxidize fatty acids, although overlap exists. We previously demonstrated that MΦ fatty acid transport protein 1 (FATP1, Slc27a1) was necessary to maintain the oxidative and anti-inflammatory AAM phenotype in vivo in a model of diet-induced obesity. The aim of this study was to examine how MΦ metabolic reprogramming through FATP1 ablation affects the process of atherogenesis. We hypothesized that FATP1 limits MΦ-mediated inflammation during atherogenesis. Thus, mice lacking MΦ Fatp1 would display elevated formation of atherosclerotic lesions in a mouse model lacking the low-density lipoprotein (LDL) receptor (Ldlr−/−). We transplanted bone marrow collected from Fatp1+/+ or Fatp1−/− mice into Ldlr−/− mice and fed chimeric mice a Western diet for 12 weeks. Body weight, blood glucose, and plasma lipids were measured. Aortic sinus and aorta lesions were quantified. Atherosclerotic plaque composition, oxidative stress, and inflammation were analyzed histologically. Compared to Fatp1+/+Ldlr−/− mice, Fatp1−/−Ldlr−/− mice exhibited significantly larger lesion area and elevated oxidative stress and inflammation in the atherosclerotic plaque. Macrophage and smooth muscle cell content did not differ by Fatp1 genotype. There were no significant systemic alterations in LDL, high-density lipoprotein (HDL), total cholesterol, or triacylglyceride, suggesting that the effect was local to the cells of the vessel microenvironment in a Fatp1-dependent manner. MΦ Fatp1 limits atherogenesis and may be a viable target to metabolically reprogram MΦs. •Lack of Fatp1 led to increased atherosclerotic lesions in Ldlr−/− mice.•Larger lesions in Fatp1−/−Ldlr−/− mice were not due to systemic changes in lipids.•Lesions in Fatp1−/−Ldlr−/− mice had greater oxidative stress and inflammation.
doi_str_mv 10.1016/j.atherosclerosis.2017.10.009
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5705203</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021915017313291</els_id><sourcerecordid>1952101099</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-1370780b01422d67e6a8d725456ea1bfc5edd4c491ef4a95b0402340a5bc69233</originalsourceid><addsrcrecordid>eNqNkcFu1DAURS0EokPLLyBvkNhk-uzYcbwACVVtQRqpG7q2HPuFekjiwc5UKl_Aup_Il-BoSlVYsbC9uOfdZ91LyFsGawasOd2u7XyDKWY3LHfIaw5MFW0NoJ-RFWuVrphoxXOyAuCs0kzCEXmV8xYAhGLtS3LENdRStWxFrjbWfaOxp-MdDjF4emHnHaNhcgltxkyfbpuDowPmECeaww8sFN34If36eX9aDh2DwxPyordDxtcP7zG5vjj_cvap2lxdfj77uKmc0HquWK1AtdABE5z7RmFjW6-4FLJBy7reSfReFJZhL6yWHQjgtQArO9doXtfH5MPBd7fvRvQOpznZwexSGG26M9EG87cyhRvzNd4aqUByWAzePRik-H2PeTZjyA6HwU4Y99kwLXkJHLQu6PsD6koQOWH_uIaBWUoxW_NPKWYpZZFLKWX-zdO_Pk7_aaEAlwcAS2K3AZPJLuDk0IeEbjY-hv9c9Rv6dqpC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1952101099</pqid></control><display><type>article</type><title>Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr−/− mice</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zhao, Liyang ; Cozzo, Alyssa J. ; Johnson, Amy R. ; Christensen, Taylor ; Freemerman, Alex J. ; Bear, James E. ; Rotty, Jeremy D. ; Bennett, Brian J. ; Makowski, Liza</creator><creatorcontrib>Zhao, Liyang ; Cozzo, Alyssa J. ; Johnson, Amy R. ; Christensen, Taylor ; Freemerman, Alex J. ; Bear, James E. ; Rotty, Jeremy D. ; Bennett, Brian J. ; Makowski, Liza</creatorcontrib><description>Altered metabolism is an important regulator of macrophage (MΦ) phenotype, which contributes to inflammatory diseases such as atherosclerosis. Broadly, pro-inflammatory, classically-activated MΦs (CAM) are glycolytic while alternatively-activated MΦs (AAM) oxidize fatty acids, although overlap exists. We previously demonstrated that MΦ fatty acid transport protein 1 (FATP1, Slc27a1) was necessary to maintain the oxidative and anti-inflammatory AAM phenotype in vivo in a model of diet-induced obesity. The aim of this study was to examine how MΦ metabolic reprogramming through FATP1 ablation affects the process of atherogenesis. We hypothesized that FATP1 limits MΦ-mediated inflammation during atherogenesis. Thus, mice lacking MΦ Fatp1 would display elevated formation of atherosclerotic lesions in a mouse model lacking the low-density lipoprotein (LDL) receptor (Ldlr−/−). We transplanted bone marrow collected from Fatp1+/+ or Fatp1−/− mice into Ldlr−/− mice and fed chimeric mice a Western diet for 12 weeks. Body weight, blood glucose, and plasma lipids were measured. Aortic sinus and aorta lesions were quantified. Atherosclerotic plaque composition, oxidative stress, and inflammation were analyzed histologically. Compared to Fatp1+/+Ldlr−/− mice, Fatp1−/−Ldlr−/− mice exhibited significantly larger lesion area and elevated oxidative stress and inflammation in the atherosclerotic plaque. Macrophage and smooth muscle cell content did not differ by Fatp1 genotype. There were no significant systemic alterations in LDL, high-density lipoprotein (HDL), total cholesterol, or triacylglyceride, suggesting that the effect was local to the cells of the vessel microenvironment in a Fatp1-dependent manner. MΦ Fatp1 limits atherogenesis and may be a viable target to metabolically reprogram MΦs. •Lack of Fatp1 led to increased atherosclerotic lesions in Ldlr−/− mice.•Larger lesions in Fatp1−/−Ldlr−/− mice were not due to systemic changes in lipids.•Lesions in Fatp1−/−Ldlr−/− mice had greater oxidative stress and inflammation.</description><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/j.atherosclerosis.2017.10.009</identifier><identifier>PMID: 29035781</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Animals ; Aorta - metabolism ; Aorta - pathology ; Aortic Diseases - genetics ; Aortic Diseases - metabolism ; Aortic Diseases - pathology ; Atherosclerosis - genetics ; Atherosclerosis - metabolism ; Atherosclerosis - pathology ; Blood Glucose - metabolism ; Bone Marrow Transplantation ; Cells, Cultured ; Cellular Microenvironment ; Disease Models, Animal ; FATP1 ; Fatty acid transport protein ; Fatty Acid Transport Proteins - deficiency ; Fatty Acid Transport Proteins - genetics ; Genetic Predisposition to Disease ; Inflammation - genetics ; Inflammation - metabolism ; Inflammation - pathology ; LDL receptor ; Lipids - blood ; Macrophage ; Macrophage Activation ; Macrophages, Peritoneal - metabolism ; Male ; Metabolic reprogram ; Mice, Knockout ; Oxidative Stress ; Phenotype ; Plaque, Atherosclerotic ; Receptors, LDL - deficiency ; Receptors, LDL - genetics ; Transplantation Chimera</subject><ispartof>Atherosclerosis, 2017-11, Vol.266, p.182-189</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-1370780b01422d67e6a8d725456ea1bfc5edd4c491ef4a95b0402340a5bc69233</citedby><cites>FETCH-LOGICAL-c499t-1370780b01422d67e6a8d725456ea1bfc5edd4c491ef4a95b0402340a5bc69233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021915017313291$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29035781$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhao, Liyang</creatorcontrib><creatorcontrib>Cozzo, Alyssa J.</creatorcontrib><creatorcontrib>Johnson, Amy R.</creatorcontrib><creatorcontrib>Christensen, Taylor</creatorcontrib><creatorcontrib>Freemerman, Alex J.</creatorcontrib><creatorcontrib>Bear, James E.</creatorcontrib><creatorcontrib>Rotty, Jeremy D.</creatorcontrib><creatorcontrib>Bennett, Brian J.</creatorcontrib><creatorcontrib>Makowski, Liza</creatorcontrib><title>Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr−/− mice</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><description>Altered metabolism is an important regulator of macrophage (MΦ) phenotype, which contributes to inflammatory diseases such as atherosclerosis. Broadly, pro-inflammatory, classically-activated MΦs (CAM) are glycolytic while alternatively-activated MΦs (AAM) oxidize fatty acids, although overlap exists. We previously demonstrated that MΦ fatty acid transport protein 1 (FATP1, Slc27a1) was necessary to maintain the oxidative and anti-inflammatory AAM phenotype in vivo in a model of diet-induced obesity. The aim of this study was to examine how MΦ metabolic reprogramming through FATP1 ablation affects the process of atherogenesis. We hypothesized that FATP1 limits MΦ-mediated inflammation during atherogenesis. Thus, mice lacking MΦ Fatp1 would display elevated formation of atherosclerotic lesions in a mouse model lacking the low-density lipoprotein (LDL) receptor (Ldlr−/−). We transplanted bone marrow collected from Fatp1+/+ or Fatp1−/− mice into Ldlr−/− mice and fed chimeric mice a Western diet for 12 weeks. Body weight, blood glucose, and plasma lipids were measured. Aortic sinus and aorta lesions were quantified. Atherosclerotic plaque composition, oxidative stress, and inflammation were analyzed histologically. Compared to Fatp1+/+Ldlr−/− mice, Fatp1−/−Ldlr−/− mice exhibited significantly larger lesion area and elevated oxidative stress and inflammation in the atherosclerotic plaque. Macrophage and smooth muscle cell content did not differ by Fatp1 genotype. There were no significant systemic alterations in LDL, high-density lipoprotein (HDL), total cholesterol, or triacylglyceride, suggesting that the effect was local to the cells of the vessel microenvironment in a Fatp1-dependent manner. MΦ Fatp1 limits atherogenesis and may be a viable target to metabolically reprogram MΦs. •Lack of Fatp1 led to increased atherosclerotic lesions in Ldlr−/− mice.•Larger lesions in Fatp1−/−Ldlr−/− mice were not due to systemic changes in lipids.•Lesions in Fatp1−/−Ldlr−/− mice had greater oxidative stress and inflammation.</description><subject>Animals</subject><subject>Aorta - metabolism</subject><subject>Aorta - pathology</subject><subject>Aortic Diseases - genetics</subject><subject>Aortic Diseases - metabolism</subject><subject>Aortic Diseases - pathology</subject><subject>Atherosclerosis - genetics</subject><subject>Atherosclerosis - metabolism</subject><subject>Atherosclerosis - pathology</subject><subject>Blood Glucose - metabolism</subject><subject>Bone Marrow Transplantation</subject><subject>Cells, Cultured</subject><subject>Cellular Microenvironment</subject><subject>Disease Models, Animal</subject><subject>FATP1</subject><subject>Fatty acid transport protein</subject><subject>Fatty Acid Transport Proteins - deficiency</subject><subject>Fatty Acid Transport Proteins - genetics</subject><subject>Genetic Predisposition to Disease</subject><subject>Inflammation - genetics</subject><subject>Inflammation - metabolism</subject><subject>Inflammation - pathology</subject><subject>LDL receptor</subject><subject>Lipids - blood</subject><subject>Macrophage</subject><subject>Macrophage Activation</subject><subject>Macrophages, Peritoneal - metabolism</subject><subject>Male</subject><subject>Metabolic reprogram</subject><subject>Mice, Knockout</subject><subject>Oxidative Stress</subject><subject>Phenotype</subject><subject>Plaque, Atherosclerotic</subject><subject>Receptors, LDL - deficiency</subject><subject>Receptors, LDL - genetics</subject><subject>Transplantation Chimera</subject><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcFu1DAURS0EokPLLyBvkNhk-uzYcbwACVVtQRqpG7q2HPuFekjiwc5UKl_Aup_Il-BoSlVYsbC9uOfdZ91LyFsGawasOd2u7XyDKWY3LHfIaw5MFW0NoJ-RFWuVrphoxXOyAuCs0kzCEXmV8xYAhGLtS3LENdRStWxFrjbWfaOxp-MdDjF4emHnHaNhcgltxkyfbpuDowPmECeaww8sFN34If36eX9aDh2DwxPyordDxtcP7zG5vjj_cvap2lxdfj77uKmc0HquWK1AtdABE5z7RmFjW6-4FLJBy7reSfReFJZhL6yWHQjgtQArO9doXtfH5MPBd7fvRvQOpznZwexSGG26M9EG87cyhRvzNd4aqUByWAzePRik-H2PeTZjyA6HwU4Y99kwLXkJHLQu6PsD6koQOWH_uIaBWUoxW_NPKWYpZZFLKWX-zdO_Pk7_aaEAlwcAS2K3AZPJLuDk0IeEbjY-hv9c9Rv6dqpC</recordid><startdate>20171101</startdate><enddate>20171101</enddate><creator>Zhao, Liyang</creator><creator>Cozzo, Alyssa J.</creator><creator>Johnson, Amy R.</creator><creator>Christensen, Taylor</creator><creator>Freemerman, Alex J.</creator><creator>Bear, James E.</creator><creator>Rotty, Jeremy D.</creator><creator>Bennett, Brian J.</creator><creator>Makowski, Liza</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171101</creationdate><title>Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr−/− mice</title><author>Zhao, Liyang ; Cozzo, Alyssa J. ; Johnson, Amy R. ; Christensen, Taylor ; Freemerman, Alex J. ; Bear, James E. ; Rotty, Jeremy D. ; Bennett, Brian J. ; Makowski, Liza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-1370780b01422d67e6a8d725456ea1bfc5edd4c491ef4a95b0402340a5bc69233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Aorta - metabolism</topic><topic>Aorta - pathology</topic><topic>Aortic Diseases - genetics</topic><topic>Aortic Diseases - metabolism</topic><topic>Aortic Diseases - pathology</topic><topic>Atherosclerosis - genetics</topic><topic>Atherosclerosis - metabolism</topic><topic>Atherosclerosis - pathology</topic><topic>Blood Glucose - metabolism</topic><topic>Bone Marrow Transplantation</topic><topic>Cells, Cultured</topic><topic>Cellular Microenvironment</topic><topic>Disease Models, Animal</topic><topic>FATP1</topic><topic>Fatty acid transport protein</topic><topic>Fatty Acid Transport Proteins - deficiency</topic><topic>Fatty Acid Transport Proteins - genetics</topic><topic>Genetic Predisposition to Disease</topic><topic>Inflammation - genetics</topic><topic>Inflammation - metabolism</topic><topic>Inflammation - pathology</topic><topic>LDL receptor</topic><topic>Lipids - blood</topic><topic>Macrophage</topic><topic>Macrophage Activation</topic><topic>Macrophages, Peritoneal - metabolism</topic><topic>Male</topic><topic>Metabolic reprogram</topic><topic>Mice, Knockout</topic><topic>Oxidative Stress</topic><topic>Phenotype</topic><topic>Plaque, Atherosclerotic</topic><topic>Receptors, LDL - deficiency</topic><topic>Receptors, LDL - genetics</topic><topic>Transplantation Chimera</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Liyang</creatorcontrib><creatorcontrib>Cozzo, Alyssa J.</creatorcontrib><creatorcontrib>Johnson, Amy R.</creatorcontrib><creatorcontrib>Christensen, Taylor</creatorcontrib><creatorcontrib>Freemerman, Alex J.</creatorcontrib><creatorcontrib>Bear, James E.</creatorcontrib><creatorcontrib>Rotty, Jeremy D.</creatorcontrib><creatorcontrib>Bennett, Brian J.</creatorcontrib><creatorcontrib>Makowski, Liza</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Liyang</au><au>Cozzo, Alyssa J.</au><au>Johnson, Amy R.</au><au>Christensen, Taylor</au><au>Freemerman, Alex J.</au><au>Bear, James E.</au><au>Rotty, Jeremy D.</au><au>Bennett, Brian J.</au><au>Makowski, Liza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr−/− mice</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>2017-11-01</date><risdate>2017</risdate><volume>266</volume><spage>182</spage><epage>189</epage><pages>182-189</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><abstract>Altered metabolism is an important regulator of macrophage (MΦ) phenotype, which contributes to inflammatory diseases such as atherosclerosis. Broadly, pro-inflammatory, classically-activated MΦs (CAM) are glycolytic while alternatively-activated MΦs (AAM) oxidize fatty acids, although overlap exists. We previously demonstrated that MΦ fatty acid transport protein 1 (FATP1, Slc27a1) was necessary to maintain the oxidative and anti-inflammatory AAM phenotype in vivo in a model of diet-induced obesity. The aim of this study was to examine how MΦ metabolic reprogramming through FATP1 ablation affects the process of atherogenesis. We hypothesized that FATP1 limits MΦ-mediated inflammation during atherogenesis. Thus, mice lacking MΦ Fatp1 would display elevated formation of atherosclerotic lesions in a mouse model lacking the low-density lipoprotein (LDL) receptor (Ldlr−/−). We transplanted bone marrow collected from Fatp1+/+ or Fatp1−/− mice into Ldlr−/− mice and fed chimeric mice a Western diet for 12 weeks. Body weight, blood glucose, and plasma lipids were measured. Aortic sinus and aorta lesions were quantified. Atherosclerotic plaque composition, oxidative stress, and inflammation were analyzed histologically. Compared to Fatp1+/+Ldlr−/− mice, Fatp1−/−Ldlr−/− mice exhibited significantly larger lesion area and elevated oxidative stress and inflammation in the atherosclerotic plaque. Macrophage and smooth muscle cell content did not differ by Fatp1 genotype. There were no significant systemic alterations in LDL, high-density lipoprotein (HDL), total cholesterol, or triacylglyceride, suggesting that the effect was local to the cells of the vessel microenvironment in a Fatp1-dependent manner. MΦ Fatp1 limits atherogenesis and may be a viable target to metabolically reprogram MΦs. •Lack of Fatp1 led to increased atherosclerotic lesions in Ldlr−/− mice.•Larger lesions in Fatp1−/−Ldlr−/− mice were not due to systemic changes in lipids.•Lesions in Fatp1−/−Ldlr−/− mice had greater oxidative stress and inflammation.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>29035781</pmid><doi>10.1016/j.atherosclerosis.2017.10.009</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9150
ispartof Atherosclerosis, 2017-11, Vol.266, p.182-189
issn 0021-9150
1879-1484
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5705203
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Aorta - metabolism
Aorta - pathology
Aortic Diseases - genetics
Aortic Diseases - metabolism
Aortic Diseases - pathology
Atherosclerosis - genetics
Atherosclerosis - metabolism
Atherosclerosis - pathology
Blood Glucose - metabolism
Bone Marrow Transplantation
Cells, Cultured
Cellular Microenvironment
Disease Models, Animal
FATP1
Fatty acid transport protein
Fatty Acid Transport Proteins - deficiency
Fatty Acid Transport Proteins - genetics
Genetic Predisposition to Disease
Inflammation - genetics
Inflammation - metabolism
Inflammation - pathology
LDL receptor
Lipids - blood
Macrophage
Macrophage Activation
Macrophages, Peritoneal - metabolism
Male
Metabolic reprogram
Mice, Knockout
Oxidative Stress
Phenotype
Plaque, Atherosclerotic
Receptors, LDL - deficiency
Receptors, LDL - genetics
Transplantation Chimera
title Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr−/− mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T10%3A37%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lack%20of%20myeloid%20Fatp1%20increases%20atherosclerotic%20lesion%20size%20in%20Ldlr%E2%88%92/%E2%88%92%20mice&rft.jtitle=Atherosclerosis&rft.au=Zhao,%20Liyang&rft.date=2017-11-01&rft.volume=266&rft.spage=182&rft.epage=189&rft.pages=182-189&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/j.atherosclerosis.2017.10.009&rft_dat=%3Cproquest_pubme%3E1952101099%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1952101099&rft_id=info:pmid/29035781&rft_els_id=S0021915017313291&rfr_iscdi=true